In the closing of the recent trading day, Tenet Healthcare (THC) stood at $191.2, denoting a +2.2% m

Tenet Healthcare is expanding its outpatient footprint through USPI, with strong first-quarter resul

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

The Zacks Medical-Hospital industry is adapting as care shifts beyond inpatient settings, demand ris

TD Cowen analyst Ryan Langston maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the pr

Large-cap laggards last week were pressured by weak guidance, regulatory concerns, rising bond yield

Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and lowers th

Baird analyst Michael Ha maintains Tenet Healthcare (NYSE:THC) with a Neutral and lowers the pric

Stephens & Co. analyst Raj Kumar maintains Tenet Healthcare (NYSE:THC) with a Overweight and

RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and lower

Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the

Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and lo

Keybanc analyst Matthew Gillmor maintains Tenet Healthcare (NYSE:THC) with a Overweight and lower

Tenet Healthcare posts Q1 earnings beat but revenue miss as payer mix shifts and external disruption

Tenet Healthcare (NYSE:THC) raises FY2026 Adj EPS guidance from $16.19-$18.47 to $16.38-$18.68 vs $1

Tenet Healthcare (NYSE:THC) reported quarterly earnings of $4.82 per share which beat the analyst co

https://www.medicaid.gov/federal-policy-guidance/downloads/sho26001.pdf

U.S. stocks rebound as investors look past rising oil prices and focus on the Fed's rate decisio

Top analysts change outlook on top names. HC Wainwright cut BWAY price target, Mizuho raised PENN ta

Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the

Mizuho analyst Ann Hynes maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the p

Leerink Partners analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Outperform and ra

Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:THC) with a Buy and ra

Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises th

Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the

Jefferies analyst Brian Tanquilut maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the

RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and raise

UBS analyst A.J. Rice maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price targe

Keybanc analyst Matthew Gillmor maintains Tenet Healthcare (NYSE:THC) with a Overweight and raise

Tenet Healthcare beats Q4 estimates on strong hospital and surgery demand, lifts 2026 outlook, and s

Tenet Healthcare (NYSE:THC) is looking for FY2026 Adj EPS of $16.19-$18.47 vs $16.45 analyst estimat

Tenet Healthcare (NYSE:THC) reported quarterly earnings of $4.70 per share which beat the analyst co

RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and raise

Although Tenet's financial statement close process is not yet fully completed, the Company curre

Tenet Healthcare Corporation (NYSE:THC) today announced the completion of a strategic transaction wi

Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and lo

BofA warns hospitals face profit and volume pressure from policy cuts, favors post-acute care, upgra

TD Cowen analyst Ryan Langston maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the pr